Assessing the use of BreatheSmart® mobile technology in adult patients with asthma: a remote observational study

Emilie Melvin, Anna Cushing, Anne Tam, Ruri Kitada, Melissa Manice, Emilie Melvin, Anna Cushing, Anne Tam, Ruri Kitada, Melissa Manice

Abstract

Introduction: Non-adherence to asthma daily controller medications is a common problem, reported to be responsible for 60% of asthma-related hospitalisations. The mean level of adherence for asthma medications is estimated to be as low as 22%. Therefore, objective measurements of adherence to medicine are necessary. This virtual observational study is designed to measure the usability of an electronic monitoring device platform that measures adherence. Understanding how patients use the BreatheSmart mobile technology at home is essential to assess its feasibility as a solution to improve medication adherence. We anticipate this approach can be applied to real-world environments as a cost-effective solution to improve medication adherence.

Methods and analysis: This is a virtual 6-month observational study of 100 adults (≥18 years) with an asthma diagnosis, using inhaled corticosteroids for at least 3 months. Participants will be recruited in the USA through ad placements online. All participants receive wireless Bluetooth-enabled inhaler sensors that track medication usage and an mSpirometerTM capable of clinical-grade lung function measurements, and download the BreatheSmart mobile application that transmits data to a secure server. All analyses are based on an intention-to-treat. Usability is assessed by patient questionnaires and question sessions. Simple paired t-test is used to assess significant change in Asthma Control Test score, quality of life (EuroQol-5D questionnaire) and lung function.

Ethics and dissemination: No ethical or safety concerns pertain to the collection of these data. Results of this research are planned to be published as soon as available.

Trial registration number: NCT03103880.

Keywords: asthma; asthma control; inhaled corticosteroids; mHealth; medication adherence; mobile health; patientmonitoring; real-time reminders; telehealth; telemanagement; telemedicine; text message reminders.

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
CONSORT flow diagram. PFT, pulmonary function test.

References

    1. National Institutes of Health: National Heart LaBI. Morbidity & Mortality: 2012 Chart Bookk on Cardiovascular, lung, and blood diseases: National Institutes of Health, 2012.
    1. Lethbridge-Cejku M, Schiller JS, Bernadel L, et al. . Summary health statistics for U.S. adults: National Health Interview Survey, 2002. Vital and health statistics Series 10, Data from the National Health Survey 2004;222:1–151.
    1. Sullivan PW, Slejko JF, Ghushchyan VH, et al. . The relationship between asthma, asthma control and economic outcomes in the United States. J Asthma 2014;51:769–78.
    1. Sullivan PW, Ghushchyan VH, Slejko JF, et al. . The burden of adult asthma in the United States: evidence from the medical expenditure panel survey. J Allergy Clin Immunol 2011;127:363–9.
    1. Goldney RD, Ruffin R, Fisher LJ, et al. . Asthma symptoms associated with depression and lower quality of life: a population survey. Med J Aust 2003;178:437–41.
    1. Meltzer EO, Blaiss MS, Nathan RA, et al. . Asthma burden in the United States: results of the 2009 Asthma Insight and Management survey. Allergy Asthma Proc 2012;33:36–46.
    1. Janson SL, McGrath KW, Covington JK, et al. . Individualized asthma self-management improves medication adherence and markers of asthma control. J Allergy Clin Immunol 2009;123:840–6.
    1. Prevention CfDCa. Asthma in the US: growing every year. 2011. .
    1. Bahadori K, Doyle-Waters MM, Marra C, et al. . Economic burden of asthma: a systematic review. BMC Pulm Med 2009;9:24
    1. Bårnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care 2015;60:455–68.
    1. National Asthma Education and Prevention Program TEPotDaMoA. Expert Panel Report 3: guidelines for the diagnosis and management of Asthma. Bethesda (MD): National Heart, lung, and Blood Institute (US), 2007.
    1. Williams LK, Peterson EL, Wells K, et al. . Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol 2011;128:1185–91.
    1. Murphy AC, Proeschal A, Brightling CE, et al. . The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 2012;67:751–3.
    1. Williams LK, Peterson EL, Wells K, et al. . A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. J Allergy Clin Immunol 2010;126:225–31.
    1. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994;149:S69–S76. discussion S7-8
    1. Sumino K, Cabana MD. Medication adherence in asthma patients. Curr Opin Pulm Med 2013;19:49–53.
    1. Morton RW, Everard ML, Elphick HE. Adherence in childhood asthma: the elephant in the room. Arch Dis Child 2014;99:949–53.
    1. Krishnan JA, Bender BG, Wamboldt FS, et al. . Adherence to inhaled corticosteroids: an ancillary study of the childhood asthma management program clinical trial. J Allergy Clin Immunol 2012;129:112–8.
    1. Foster JM, Usherwood T, Smith L, et al. . Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. J Allergy Clin Immunol 2014;134:1260–8.
    1. Latry P, Pinet M, Labat A, et al. . Adherence to anti-inflammatory treatment for asthma in clinical practice in France. Clin Ther 2008;30:1058–68. Spec No
    1. Morton RW, Elphick HE, Rigby AS, et al. . STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma. Thorax 2017;72
    1. Bush A, Fleming L. Is asthma overdiagnosed? Arch Dis Child 2016;101:688–9.
    1. Klersy C, De Silvestri A, Gabutti G, et al. . A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol 2009;54:1683–94.
    1. Polisena J, Tran K, Cimon K, et al. . Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab 2009;11:913–30.
    1. Russell-Minda E, Jutai J, Speechley M, et al. . Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol 2009;3:1460–71.
    1. Howard S, Lang A, Sharples S, et al. . What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective. BMJ Open Respir Res 2016;3:e000159
    1. Federico MJ, Hoch HE, Anderson WC, et al. . Asthma Management for Children: risk identification and Prevention. Adv Pediatr 2016;63:103–26.
    1. Voorend-van Bergen S, Vaessen-Verberne AA, Brackel HJ, et al. . Monitoring strategies in children with asthma: a randomised controlled trial. Thorax 2015;70:543–50.
    1. Zhao J, Zhai YK, Zhu WJ, et al. . Effectiveness of Telemedicine for Controlling Asthma Symptoms: a systematic review and Meta-analysis. Telemed J E Health 2015;21:484–92.
    1. Kenyon CC, Chang J, Wynter SA, et al. . Electronic adherence monitoring in a High-Utilizing Pediatric Asthma Cohort: a Feasibility Study. JMIR Res Protoc 2016;5:e132
    1. Vasbinder EC, Goossens LM, Rutten-van Mölken MP, et al. . e-Monitoring of Asthma therapy to improve compliance in children (e-MATIC): a randomised controlled trial. Eur Respir J 2016;48:758–67.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren